Advanced Analytics. Intelligent Insights.
Your medical imaging partner, we support biopharmaceutical companies across all phases of CNS clinical research.
Consultancy
We can work with you on the selection and use of medical imaging and digital biomarkers for your drug development programs, directly and as part of collaborative consortia.
Early Phase
We are experts in the definition and delivery of early phase clinical development, where rigorous patient safety runs hand-in-hand with flexibility around trial design and data analytics.
Late Phase
Our global network of over 2,000 imaging centers across 75 countries ensures large-scale trials can be set up quickly and efficiently, while our custom TrialTracker platform delivers highly reliable, regulatory compliant data.
Post-Marketing
We understand the challenges of extended longitudinal studies. We support you to monitor patient safety and drug utilization for ongoing optimization of patient pathways post-marketing.
Specialist Therapeutic Focus
We have focused exclusively on neurological disorders since 2004, and our growing team are renowned experts in CNS therapeutics. We combine specialist neuroscience knowledge, highly curated neurological patient data and proven pipeline algorithms to accurately measure brain biomarkers.
Our world-class therapeutic expertise, breakthrough technology and analytics, and operational excellence makes us the partner of choice for imaging biomarker solutions in CNS clinical trials.
Get the latest content from IXICO
Sign up below and we'll send you the latest insight, knowledge and innovations from IXICO to your inbox.
Subscribe to content